White House signals suport for biosimilars (NVS, AZN, AMGN, DNA, GENZ, GILD,...
The Obama Administration in a letter released Thursday recommended that seven years is enough time to protect brand-name biotech drugs from cheaper generic competition, roughly half the time sought by...
View ArticleValue Stocks in Drugs & Biotech (AMGN, BIIB, CBST, CEPH, PDLI)
This weekend we ran screens of several drug and biotech companies in our quest for ‘cheap stocks’ in the BioHealth sector. The intent is not solely for buyout targets because we prefer to look at...
View ArticleGeneric Drug Wars… Is Dr. Reddy’s The Answer? (RDY, TEVA, GSK)
Generic drugs are just one of the many combined issues that are coming front and center in the world of healthcare reform. Frankly this is not a new notion. Not all. This weekend came a feature in...
View ArticleClik here to view.
The Changing Landscape of Biotech Valuations (ACOR, CBST, MNKD, INCY, SGEN,...
The biotech and biohealth universe is changing in size. In 2008 and 2009, partly due to mergers and partly due to market valuations, there had become a surprisingly small number of biotech stocks...
View ArticleTeva Could Be Seeking Mega-Cap Status (TEVA, PFE, NVS, MRK, SNY)
Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) is slowly becoming one of the biggest drug makers in the world. This morning the company is up on the news that it won the bidding process to...
View ArticleMomenta Skyrockets On FDA Approval
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) was up $7.62 (63.87%) this morning to $19.55 on the recent FDA approval of a generic, yet therapeutically equivalent, Lovenox. The drug is enoxaparin...
View ArticleSanofi-Aventis Prepares $70/share Bid For Genzyme
According to Bloomberg, the Sanofi-Aventis (NYSE: SNY) last week to potentially purchase generic drugmaker Genzyme Corp. (NASDAQ: GENZ) is on track to become an actual bid, worth potentially as much as...
View ArticleHow Safe is Teva? (TEVA)
This week we started compiling a list of safe stocks for a new bear market, and Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) came up in our screens. We ran the piece during this morning...
View ArticlePrana Biotechnology Secures Crucial Patents In Europe and the U.S.
Prana Biotechnology (NASDAQ: PRAN) is up 8.77% a half hour before close after announcing this morning that it had secured several key patent extensions from the United States Patents and Trademark...
View ArticleTeva Raises Capital (TEVA)
Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) is not exactly one of the first companies we would think of as offering a bond issue, and it might normally lead us to think that Teva was on the...
View Article
